Showing results (2231-2240 of 2,259) with videos related to

Sort By:
Pageof 226
The Lancet Regional Health. Western Pacific|September 19, 2022
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialAi-Min Hui, Jingxin Li, Li Zhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2024
Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case SeriesSamih H Nasr, Surendra Dasari, Anthony M Valeri, et al.
Oncogene|May 1, 2018
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathwayJer-Wei Chang, Wen-Hung Kuo, Chiao-Mei Lin, et al.
European Cardiology|January 13, 2022
Asian Pacific Society of Cardiology Consensus Recommendations on DyslipidaemiaNatalie Koh, Brian A Ference, Stephen J Nicholls, et al.
Cell Reports. Medicine|November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trialSi-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort StudyYvette Drew, Jae-Weon Kim, Richard T Penson, et al.
Journal of Medicinal Chemistry|December 15, 2015
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.
Emerging Infectious Diseases|October 24, 2024
Detection in Orchards of Predominant Azole-Resistant Candida tropicalis Genotype Causing Human Candidemia, TaiwanKuo-Yun Tseng, Yin-Zhi Chen, Zi-Li Zhou, et al.
EMBO Molecular Medicine|May 14, 2025
Targeting transcription factors through an IMiD independent zinc finger domainBee Hui Liu, Miao Liu, Sridhar Radhakrishnan, et al.
The Lancet. Oncology|May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialJohan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Pageof 226